YolTech Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for YOLT-101, an In Vivo Base Editing Therapy to Treat Heterozygous Familial Hypercholesterolemia (HeFH)
SHANGHAI, June 6, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage biotechnology company developing in vivo genome editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's...
FutureCeuticals, Inc. Announces Peer-Reviewed Publication Highlighting Cellular Health and Immune Support Benefits of vitAlign®
MOMENCE, Ill., June 5, 2025 /PRNewswire/ -- New research published in the International Journal of Molecular Sciences shows that vitAlign®, a proprietary and comprehensive healthy aging innovation from FutureCeuticals, delivers significant benefits...
Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach
Phase IIa study results of Rentosertib were published simultaneously in Nature Medicine(IF = 58.7) and presented at the American Thoracic Society (ATS) 2025. Encouraging clinical data showed that patients receiving 60 mg QD Rentosertib experienced...
InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025
NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical trial (NCT06166836; NCT05379946)...
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I&I Conditions and U.S. FDA Clearance of IND Application for BBT001
Preclinical data with BBT002 demonstrate its best-in-disease potential for improved efficacy and dosing convenience across respiratory, dermatology, and gastroenterology indications Interim safety and pharmacokinetic data from BBT002-01 study...
Webull Announces Redemption of Incentive Warrants
ST. PETERSBURG, Fla., May 29, 2025 /PRNewswire/ -- Webull Corporation (Nasdaq: BULL) ("Webull" or the "Company"), the owner of the Webull online investment platform, announced today that it has delivered a notice of redemption to redeem on June 30,...
Arts Council Korea to Host ARKO Global Week Presenting A Global Vision: Connecting Korean Arts with the World
ARKO Global Week Spotlights Major International Events, Including the 10th World Summit on Arts and Culture and APE CAMP (May 24–30) ARKO Announces Global Vision and Strategic Initiatives to Advance Artistic Creation and Cultural Exchange...
Databricks Announces 2025 Data + AI Summit Keynote Lineup and Data Intelligence Programming
The Data Intelligence for All themed event will feature keynotes from co-founders Ali Ghodsi, Matei Zaharia, Arsalan Tavakoli-Shiraji and Reynold Xin Attendees will hear from Jamie Dimon, Chairman and CEO, JPMorgan Chase; Dario Amodei, Co-founder...
BLUETTI Launches Apex 300 on Indiegogo: Versatile Power Station for Home Backup, RVs and Off-grid Life
From a plug-and-play to a whole-home backup, Apex 300 redefines portable power, marking a huge leap for BLUETTI's flagship energy system. LAS VEGAS, May 20, 2025 /PRNewswire/ -- BLUETTI, a leading innovator in portable power and clean energy...
Acer Announces New Predator Triton 14 AI, Blending Top-Tier Laptop Gaming Performance and Creative Capabilities
Also announced the new Predator Helios Neo 14 AI laptop and Predator Orion 3000 gaming desktop, all configurable with the latest NVIDIA GeForce RTX 50 Series Editor's Summary The slim Predator Triton 14 AI supports an Intel® Core™ Ultra 9 processor...